Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study
Sign Up to like & getrecommendations! Published in 2020 at "BMC Cardiovascular Disorders"
DOI: 10.1186/s12872-020-01584-0
Abstract: Background Prourokinase is a single-chain plasminogen activator presenting with fewer hemorrhagic complications and reduced reocclusion rate compared with the conventional fibrinolytic agents in patients with coronary artery disease. However, prourokinase intracoronary injection during PCI for… read more here.
Keywords: intracoronary prourokinase; control; myocardial infarction; group ... See more keywords